INJECTION INDEXWeight management, clearly.
The online care edition
October 2026
Offer profile · October 7, 2026

Shed Review

Shed advertises compounded semaglutide from $159 and a conditional 120-day guarantee; its wider wellness catalogue and outcome headlines are separate records.

Read this firstSources checked October 7, 2026

Shed publishes starting prices for two compounded injections and a conditional guarantee. Compare the medicine and the guarantee terms separately.

Compounded semaglutide
$159

Advertised starting monthly figure.

Compounded tirzepatide
$239

A different preparation and starting monthly figure.

Shed presents weight care within a larger wellness catalogue that also includes hair and longevity products. The weight-loss offer advertises compounded semaglutide from $159 per month and a separate tirzepatide starting rate. Those are specific offers within the catalogue, not a universal price for every Shed service.

The homepage’s 120-day weight-loss guarantee makes its commercial proposition memorable. The accompanying terms qualification matters just as much. This review describes the offer without treating a guarantee as a trial result or promising that a particular reader will receive money back.

The details, visualized

Shed advertised injection starting prices

Advertised US dollars; billing scope shown on every row

  1. Compounded semaglutide$159

    Advertised starting monthly figure.

  2. Compounded tirzepatide$239

    A different preparation and starting monthly figure.

Provider-advertised information checked October 7, 2026. Items can have different inclusions or commitments; read each row before comparing. Calculations are labeled.

View the printable chart imageShed advertised injection starting prices. The same values and context are available in the data table above.
Research note 01

The guarantee is a separate commercial document

The homepage presents a 120-day weight-loss guarantee alongside the product menu. Its existence does not establish that every new customer is likely to reach the stated result or that every order is refundable. Eligibility, documentation and adherence requirements should be read before treating the guarantee as part of the financial value.

The semaglutide and tirzepatide starting figures belong to different medicines. Request the actual selected plan, supplied amount and continuing price. If the quote includes another supplement or treatment, keep that item separate so the injection cost remains visible.

Research note 02

Program scale does not describe individual follow-up

Customer counts and selected stories may describe the size of a platform but do not answer who reviews symptoms or authorizes the next refill. Ask about appointment access, communication during a medication hold, and how the pharmacy can be reached if the parcel raises a storage question.

Before you decide

Questions worth answering

What is the most useful detail to verify before choosing Shed?

Shed publishes starting prices for two compounded injections and a conditional guarantee. Compare the medicine and the guarantee terms separately. Save the selected product name, payment or supply period, and the source or agreement that confirms it. A written record makes later changes easier to identify.

Does this review establish how much weight I would lose?

No. This is a review of public offer information, including its billing and service model. A provider advertisement, testimonial, or trial of a branded medicine does not establish the outcome of an individual order from Shed.

Evidence behind this page

Sources & chart notes

Checked October 7, 2026. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.

Editorial illustration: a telehealth screen, a question card and an unbranded container.
Shed Review — keep the product information and the route for asking a question in the same comparison.

The advertised medicine determines the quote

The reviewed weight-care section names compounded semaglutide at an as-low-as $159 monthly rate and a separate compounded tirzepatide starting figure. A weight-loss heading can contain several treatments, so a quote needs to identify which preparation and commitment it actually covers.

The page also advertises other wellness products at other rates. Their ingredients, purposes and offers cannot be added to the GLP-1 package by proximity. The cost guide explains why a selected medicine and complete term matter more than the catalogue’s lowest figure.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
The advertised medicine determines the quote — keep the exact product identity and its complete label together.

The guarantee is conditional commercial language

Shed advertises loss of 5% within 120 days or money back, with terms and conditions explicitly applying. That is a conditional refund offer. It is not proof that every member achieves that change, nor evidence that this review tested the program.

The exact qualifying requirements, documentation and exclusions would determine a refund request. They should not be filled in from the headline alone. The renewal and refund guide separates an advertised promise from a specific contractual right and a completed refund. In particular, an outcome-linked guarantee deserves a different reading from a refund when the clinician does not approve treatment.

Large program totals do not predict a person

The homepage promotes total pounds lost and a large membership count. These are aggregate program claims, not a measured average for a defined person, medicine or duration. A large cumulative figure does not identify the denominator or supply an individual expectation.

The compounded-product identity also needs to remain explicit. FDA says compounded GLP-1 preparations do not undergo the agency’s premarket review as approved finished drugs. A branded trial percentage or familiar active name does not establish an equivalent outcome from every dispensed preparation.

Editorial illustration: an unbranded container, information sheet and magnifying glass.
Large program totals do not predict a person — keep the exact product identity and its complete label together.

The practical strength and the open question

Shed makes its major treatment category and conditional guarantee visible, alongside an online access model. The useful open question is the complete selected prescription and purchase agreement, including what renews and how the guarantee works. This review did not complete an intake, buy a product or assess eligibility.

The Enhance.MD review distinguishes an introductory rate from the ongoing amount. The Embody review follows another low starting offer. The treatment guide provides context for medicine identity without treating the lowest advertised price as a clinical ranking.

Compare another model

Brightmeds · Enhance.MD · SnagRx · BetterMe Rx

The invoice guide and product-status guide explain the distinctions behind these entries.

Research record

Documents used

Source register refreshed October 7, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.

  1. Shed: Official program and offer information ↗
  2. FDA: Concerns with unapproved GLP-1 drugs ↗